保立佳(301037) - 2025 Q1 - 季度财报

Revenue Performance - Revenue for Q1 2025 was CNY 425,441,299.89, a decrease of 12.09% compared to CNY 483,956,273.87 in the same period last year[6]. - Total operating revenue decreased to ¥425,441,299.89 from ¥483,956,273.87, representing a decline of approximately 12%[22]. Profitability - Net profit attributable to shareholders improved to CNY -10,347,259.13, a 61.77% increase from CNY -27,062,758.85 year-over-year[6]. - Net profit for the period was a loss of ¥10,415,486.70, compared to a loss of ¥27,057,903.58 in the previous period, showing an improvement of approximately 61%[24]. - Basic and diluted earnings per share improved to CNY -0.0742, a 72.52% increase from CNY -0.27 in the same period last year[6]. - The company reported a basic and diluted earnings per share of -¥0.0742, compared to -¥0.27 in the previous period[24]. Cash Flow - Operating cash flow turned positive at CNY 67,232,746.84, a significant improvement of 163.94% from CNY -105,143,354.89 in the previous year[6]. - Net cash flow from operating activities was $67.23 million, a significant improvement from a net outflow of $105.14 million in the previous period[27]. - Cash flow from operating activities was ¥276,503,935.54, slightly down from ¥278,854,887.28 in the previous period[26]. - Cash inflow from operating activities totaled $280.28 million, slightly down from $281.93 million, showing a marginal decline of 0.6%[27]. Assets and Liabilities - Total assets increased by 1.74% to CNY 2,545,289,608.82 compared to CNY 2,501,761,483.54 at the end of the previous year[6]. - Total liabilities increased to ¥1,919,696,259.31 from ¥1,866,004,459.31, an increase of approximately 3%[21]. - Total equity attributable to shareholders decreased to ¥622,385,721.02 from ¥632,481,168.17, a decline of about 2%[21]. Cost Management - Total operating costs decreased to ¥438,013,247.21 from ¥509,312,519.25, a reduction of about 14%[23]. - The company is focusing on cost reduction strategies, as evidenced by the significant decrease in operating costs and R&D expenses[23]. - Research and development expenses decreased by 56.09% to CNY 6,798,076.07 from CNY 15,482,553.70 year-over-year[12]. - Cash paid to employees was $28.22 million, down from $46.47 million, representing a decrease of about 39%[27]. - Cash paid for taxes was $6.97 million, significantly lower than $21.64 million, indicating a reduction of approximately 68%[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 4,897[15]. - The largest shareholder, Yang Wenyu, holds 51.92% of the shares, totaling 72,424,660 shares[15]. - The total number of restricted shares held by Yang Wenyu is 72,424,660, with 54,318,495 shares released from restrictions during the period[17]. Financing Activities - The company reported a 317.42% increase in receivables financing, reaching CNY 104,762,191.31 compared to CNY 25,097,514.63 last year[11]. - Total cash inflow from financing activities was $414.94 million, compared to $441.32 million in the prior period, indicating a slight decrease of 6%[27]. - Cash received from loans was $348.94 million, compared to $441.32 million, indicating a decrease of about 21%[27].